Calidi Biotherapeutics, Inc. Repayments of Convertible Debt
Calidi Biotherapeutics, Inc. (CLDI) reported Repayments of Convertible Debt of $300.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2025-03-31
- Calidi Biotherapeutics, Inc. repayments of convertible debt for the quarter ending 2024-12-31 was -$1.20M.
- Calidi Biotherapeutics, Inc. repayments of convertible debt for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- Calidi Biotherapeutics, Inc. repayments of convertible debt for fiscal 2023 was $300.00K.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|
| 2024-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $300.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $1.50M 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | $300.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |